Roshini Biotech Profile
Key Indicators
- Authorised Capital ₹ 45.60 Cr
as on 10-01-2025
- Paid Up Capital ₹ 45.56 Cr
as on 10-01-2025
- Company Age 22 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue %
(FY 2020)
- Profit 6.45%
(FY 2020)
- Ebitda -32.47%
(FY 2020)
- Net Worth -0.97%
(FY 2020)
- Total Assets -6.44%
(FY 2020)
About Roshini Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 45.60 Cr and a paid-up capital of Rs 45.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Yerrapareddy, Kocherlakota Jyothsna, Pulluri Reddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
U01119TG2002PTC039160
- Company No.
039160
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 2002
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Roshini Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Yerrapareddy  | Managing Director | 20-Jun-2002 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kocherlakota Jyothsna | Director | 22-Dec-2004 | Current |
| Pulluri Reddy | Whole-Time Director | 25-Mar-2005 | Current |
| Kavalakuntla Reddy | Whole-Time Director | 01-Jul-2009 | Current |
| Praveen Nareddy | Director | 29-Mar-2014 | Current |
Financial Performance of Roshini Biotech.
Roshini Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 6.45% increase in profit. The company's net worth dipped by a decrease of 0.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Roshini Biotech?
Unlock access to Roshini Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Arvg Speciality Mines Private LimitedActive 15 years 4 months
Anil Yerrapareddy, Kavalakuntla Reddy and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Roshini Biotech?
Unlock and access historical data on people associated with Roshini Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Roshini Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Roshini Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
